Monitored S.1837, Tobacco Tax Equity Act of 2017
Monitored H.R. 1136, FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
Monitored S. 3319, Stopping Appealing Flavors in E-Cigarettes for Kids Act
Monitored FDA Implementation of P.L.1111-31 (All sections of full text)
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) regarding a Tobacco Product Standard for Nicotine Level of Combusted Cigarettes
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) on Flavors in Tobacco Products
Duration: February 1, 2013
to
December 31, 2018
General Issues: Taxation/Internal Revenue Code , Tobacco , Consumer Issues/Safety/Protection , Advertising , Budget/Appropriations , Agriculture , Food Industry (Safety, Labeling, etc.)
Spending: about $660,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2018
The Smith-Free Group, LLC terminated an engagement in which they represented Ballantyne Brands LLC on Jan. 15, 2019.
Original Filing: 301004531.xml
3rd Quarter, 2018
In Q3, The Smith-Free Group, LLC lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on Oct. 15, 2018.
Original Filing: 300985628.xml
Lobbying Issues
Monitored S.1837, Tobacco Tax Equity Act of 2017
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored H.R. 1136, FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
Monitored S. 3319, Stopping Appealing Flavors in E-Cigarettes for Kids Act
Monitored FDA Implementation of P.L.1111-31 (All sections of full text)
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) regarding a Tobacco Product Standard for Nicotine Level of Combusted Cigarettes
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) on Flavors in Tobacco Products
2nd Quarter, 2018
In Q2, The Smith-Free Group, LLC lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on July 18, 2018.
Original Filing: 300967890.xml
Lobbying Issues
Monitored S.1837, Tobacco Tax Equity Act of 2017
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 1136, FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
Discussions regarding the FDA Implementation of P.L.1111-31 (All sections of full text)
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) regarding a Tobacco Product Standard for Nicotine Level of Combusted Cigarettes
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) on Flavors in Tobacco Products
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on April 20, 2018.
Original Filing: 300952638.xml
Lobbying Issues
Monitored S.1837, Tobacco Tax Equity Act of 2017
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 1136, FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
Discussions regarding the FDA Implementation of P.L.1111-31 (All sections of full text)
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) regarding a Tobacco Product Standard for Nicotine Level of Combusted Cigarettes
Monitored FDA ANPRM (Advanced Notice of Proposed Rulemaking) on Flavors in Tobacco Products
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on Jan. 19, 2018.
Original Filing: 300929099.xml
Lobbying Issues
Monitored discussions relating to Notice of Final Rule FDA for warning labels on products with liquid nicotine.
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Monitored S.1837, Tobacco Tax Equity Act of 2017
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 1136, FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
Discussions regarding the FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All Sections of full text)
Discussions regarding the FDA Implementation of P.L.1111-31 (All sections of full text)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905333.xml
Lobbying Issues
Monitored discussions relating to Notice of Final Rule FDA for warning labels on products with liquid nicotine.
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
H.R. 1136 - FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All Sections of full text)
FDA Implementation of P.L. 11-31 (All sections of full text)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitored S. 1837 Tobacco Tax Equity Act of 2017
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2017
In Q2, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on July 12, 2017.
Original Filing: 300883716.xml
Lobbying Issues
Monitored discussions relating to Notice of Final Rule FDA for warning labels on products with liquid nicotine.
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
H.R. 1136 - FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All Sections of full text)
FDA Implementation of P.L. 11-31 (All sections of full text)
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on April 17, 2017.
Original Filing: 300866338.xml
Lobbying Issues
Monitored discussions relating to Notice of Final Rule FDA for warning labels on products with liquid nicotine.
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
H.R. 1136 - FDA Deeming Authority Clarification Act of 2017 (All sections of full text)
FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All Sections of full text)
FDA Implementation of P.L. 11-31 (All sections of full text)
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on Jan. 11, 2017.
Original Filing: 300845080.xml
Lobbying Issues
Monitored H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored H.R.1517, SMOKE Act
Lobbying Issues
Monitored Public Law No: 114-116, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
Monitored discussions relating to Notice of Final Rule FDA for warning labels on products with liquid nicotine
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Monitored S.450, Tobacco Tax Equity Act of 2015
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.2058, the FDA Deeming Authority Clarification Act of 2015 (All Sections of Full Text)
FDA Implementation of P.L. 111-31 (All sections of full text)
FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All sections of full text)
H.R. 4371, A Bill that Would Concern the FDA's Pre-Market Tobacco Applications for E-Cigarettes (All sections of full text)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitored P.L.114-223, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Monitored P.L.114-254 Further Continuing and Security Assistance Appropriations Act, 2017
3rd Quarter, 2016
In Q3, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on Oct. 6, 2016.
Original Filing: 300825518.xml
Lobbying Issues
Monitored H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored H.R.1517, SMOKE Act
Lobbying Issues
Public Law No: 114-116, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
Discussions relating to Notice of Final Rule FDA for warning labels on products with liquid nicotine
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Monitored S.450, Tobacco Tax Equity Act of 2015
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.2058, the FDA Deeming Authority Clarification Act of 2015 (All Sections of Full Text)
FDA Implementation of P.L. 111-31 (All sections of full text)
FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All sections of full text)
H.R. 4371, A Bill that Would Concern the FDA's Pre-Market Tobacco Applications for E-Cigarettes (All sections of full text)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitored P.L.114-223, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
2nd Quarter, 2016
In Q2, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on July 20, 2016.
Original Filing: 300819340.xml
Lobbying Issues
Monitored H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored H.R.1517, SMOKE Act
Lobbying Issues
Public Law No: 114-116, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
Monitored discussions relating to Notice of Proposed Rulemaking FDA for warning labels on products with liquid nicotine
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Monitored S.450, Tobacco Tax Equity Act of 2015
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.2058, the FDA Deeming Authority Clarification Act of 2015 (All Sections of Full Text)
FDA Implementation of P.L. 111-31 (All sections of full text)
FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All sections of full text)
H.R. 4371, A Bill that Would Concern the FDA's Pre-Market Tobacco Applications for E-Cigarettes (All sections of full text)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5054- Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $20,000. The report was filed on April 18, 2016.
Original Filing: 300793327.xml
Lobbying Issues
Monitored H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015
Monitored H.R.1517, SMOKE Act
Lobbying Issues
Public Law No: 114-116, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
Monitored discussions relating to Notice of Proposed Rulemaking FDA for warning labels on products with liquid nicotine
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Monitored S.450, Tobacco Tax Equity Act of 2015
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.2058, the FDA Deeming Authority Clarification Act of 2015 (All Sections of Full Text)
FDA Implementation of P.L. 111-31 (All sections of full text)
FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All sections of full text)
H.R. 4371, A Bill that Would Concern the FDA's Pre-Market Tobacco Applications for E-Cigarettes (All sections of full text)
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on Jan. 19, 2016.
Original Filing: 300774887.xml
Lobbying Issues
H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015
S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015
H.R.1517, SMOKE Act
Lobbying Issues
S.142, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
Monitored discussions related to H.R.1375, Child Nicotine Poisoning Prevention Act of 2015
Monitored discussions relating to Notice of Proposed Rulemaking FDA for warning labels on products with liquid nicotine
Monitored discussions relating to H.R. 3242, Child Nicotine Poisoning Prevention Act of 2015
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
S.450, Tobacco Tax Equity Act of 2015
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
P.L. 114-113, Consolidated Appropriations Act, 2016 (Division A: Agriculture, Rural Development, Food and Drug Administration and Related Agencies)
FDA Implementation of P.L. 111-31
Monitor FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses"
H.R.2058, the FDA Deeming Authority Clarification Act of 2015 (All Sections of Full Text)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on Oct. 19, 2015.
Original Filing: 300756840.xml
Lobbying Issues
H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015 (All Sections of Full Text)
S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015 (All Sections of Full Text)
H.R.1517, To provide greater clarity in the regulation of electronic nicotine delivery systems, including electronic cigarettes, cigars, cigarillos, pipes, and hookahs, and for other purposes.(All Sections of Full Text)
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.142, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
Monitored discussions related to H.R.1375, Child Nicotine Poisoning Prevention Act of 2015 (All Sections of Full Text)
Monitored discussions relating to Notice of Proposed Rulemaking FDA for warning labels on products with liquid nicotine
Monitored discussions relating to H.R. 3242, Child Nicotine Poisoning Prevention Act of 2015 (All Sections of Full Text)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
S.450, Tobacco Tax Equity Act of 2015 (All Sections of Full Text)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
FDA Implementation of P.L.111-31, Family Smoking Prevention and Tobacco Control and Federal Retirement Reform
Monitor FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses"
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2058, the FDA Deeming Authority Clarification Act of 2015 (All Sections of Full Text)
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
In Q2, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on July 8, 2015.
Original Filing: 300732306.xml
Lobbying Issues
H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015 (All Sections of Full Text)
S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015 (All Sections of Full Text)
H.R.1517, To provide greater clarity in the regulation of electronic nicotine delivery systems, including electronic cigarettes, cigars, cigarillos, pipes, and hookahs, and for other purposes.(All Sections of Full Text)
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.142, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
H.R.1375, Child Nicotine Poisoning Prevention Act of 2015 (All Sections of Full Text)
Monitored discussions relating to Notice of Proposed Rulemaking FDA for warning labels on products with liquid nicotine
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
S.450, Tobacco Tax Equity Act of 2015 (All Sections of Full Text)
H.Con.Res.27, Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.(All Sections of Full Text)
S.Con.Res.11, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.(All Sections of Full Text)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
FDA Implementation of P.L.111-31, Family Smoking Prevention and Tobacco Control and Federal Retirement Reform
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2058, the FDA Deeming Authority Clarification Act of 2015 (All Sections of Full Text)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2015
In Q1, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on April 9, 2015.
Original Filing: 300713474.xml
Lobbying Issues
H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015
S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015
H.R.1517, To provide greater clarity in the regulation of electronic nicotine delivery systems, including electronic cigarettes, cigars, cigarillos, pipes, and hookahs, and for other purposes.
Lobbying Issues
S.142, Child Nicotine Poisoning Prevention Act of 2015 (All sections of full text)
H.R.1375, Child Nicotine Poisoning Prevention Act of 2015
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
S.450, Tobacco Tax Equity Act of 2015
H.Con.Res.27, Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
S.Con.Res.11, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
FDA Implementation of P.L.111-31, Family Smoking Prevention and Tobacco Control and Federal Retirement Reform
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on Jan. 15, 2015.
Original Filing: 300696135.xml
Lobbying Issues
HR.4325, Protecting Children from Electronic Cigarette Advertising Act of 2014 (All sections of full text)
S.2047, Protecting Children from Electronic Cigarette Advertising Act of 2014 (All sections of full text)
HR.5010, To provide greater clarity in the regulation of electronic nicotine delivery systems, including electronic cigarettes, cigars, cigarillos, pipes and hookahs, and for other purposes (All sections of full text)
Lobbying Issues
S.2581, Child Nicotine Poisoning Prevention Act of 2014 (All sections of full text)
H.R.5486, Child Nicotine Poisoning Prevention Act of 2014 (All sections of full text)
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
S.194, Tobacco Tax Equity Act of 2013 (All sections of full text)
S.39, Healthy Lifestyles and Prevention America Act (Sec. 205, Tobacco Tax Increase and Parity)
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
FDA Implementation of P.L.111-31, Family Smoking Prevention and Tobacco Control and Federal Retirement Reform
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on Oct. 20, 2014.
Original Filing: 300684917.xml
Lobbying Issues
HR.4325, Protecting Children from Electronic Cigarette Advertising Act of 2014 (All sections of full text)
S.2047, Protecting Children from Electronic Cigarette Advertising Act of 2014 (All sections of full text)
HR.5010, To provide greater clarity in the regulation of electronic nicotine delivery systems, including electronic cigarettes, cigars, cigarillos, pipes and hookahs, and for other purposes (All sections of full text)
Lobbying Issues
S.2581, Child Nicotine Poisoning Prevention Act of 2014 (All sections of full text)
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
S.194, Tobacco Tax Equity Act of 2013 (All sections of full text)
S.39, Healthy Lifestyles and Prevention America Act (Sec. 205, Tobacco Tax Increase and Parity)
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
FDA Implementation of P.L.111-31, Family Smoking Prevention and Tobacco Control and Federal Retirement Reform
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on July 18, 2014.
Original Filing: 300662535.xml
Lobbying Issues
Implementation of P.L. 111-31
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 194 Tobacco Tax Equity Act of 2013 (all sections of full text)
S. 39 Healthy Lifestyles and Prevention America Act (Sec 205 tobacco tax increase and parity)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
HR 4325 Protecting Children from Electronic Cigarette Advertising Act of 2014 (all sections of full text)
S 2047 Protecting Children from Electronic Cigarette Advertising Act of 2014 (all sections of full text)
HR 5010 To provide greater clarity in the regulation of electronic nicotine delivery systems, including electronic cigarettes, cigars, cigarillos, pipes and hookahs, and for other purposes (all sections of full text)
1st Quarter, 2014
In Q1, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $40,000. The report was filed on April 17, 2014.
Original Filing: 300638468.xml
Lobbying Issues
Implementation of P.L. 111-31
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
S. 194 Tobacco Tax Equity Act of 2013 (all sections of full text)
S. 39 Healthy Lifestyles and Prevention America Act (Sec 205 tobacco tax increase and parity)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
HR 4325 Protecting Children from Electronic Cigarette Advertising Act of 2014 (all sections of full text)
S 2047 Protecting Children from Electronic Cigarette Advertising Act of 2014 (all sections of full text)
4th Quarter, 2013
In Q4, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $30,000. The report was filed on Jan. 16, 2014.
Original Filing: 300616329.xml
Lobbying Issues
Implementation of P.L. 111-31
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
S. 194 Tobacco Tax Equity Act of 2013 (all sections of full text)
S. 39 Healthy Lifestyles and Prevention America Act (Sec 205 tobacco tax increase and parity)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
In Q3, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $30,000. The report was filed on Oct. 16, 2013.
Original Filing: 300595006.xml
Lobbying Issues
Implementation of P.L. 111-31
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
S. 194 Tobacco Tax Equity Act of 2013 (all sections of full text)
S. 39 Healthy Lifestyles and Prevention America Act (Sec 205 tobacco tax increase and parity)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
In Q2, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $30,000. The report was filed on July 22, 2013.
Original Filing: 300582243.xml
Lobbying Issues
Implementation of P.L. 111-31
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
S. 194 Tobacco Tax Equity Act of 2013 (all sections of full text)
S. 39 Healthy Lifestyles and Prevention America Act (Sec 205 tobacco tax increase and parity)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
In Q1, THE SMITH-FREE GROUP lobbied for Ballantyne Brands LLC , earning $30,000. The report was filed on April 22, 2013.
Original Filing: 300560732.xml
Lobbying Issues
Monitor FDA imlementation of P.L. 111-31
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
S. 194 Tobacco Tax Equity Act of 2013 (All sections of full text)
S. 39 Healthy Lifestyles and Prevention America Act (Sec. 205 Tobacco Tax Increase and Parity)
Type of Issue
Taxation/Internal Revenue Code
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...